KCPI

Kansas City Proton Institute Begins Cancer Treatments with Advanced MEVION S250i Proton Therapy System

Retrieved on: 
Friday, December 22, 2023
Oncology, Medical Devices, Health, Hospitals, Surgery, Radiology, Proton, Liver, Intensity, Proton therapy, Risk, Multimedia, Stomach, Physician, Lung, Breast, Spinal cord, KCPI, Brain, Doctor of Philosophy, MLC, Motion, Head, 3D, Neoplasm, Prostate, Esophagus, Patient, Radiation, Neck, Skin, Medical imaging

Kansas City Proton Institute (KCPI), the first physician-led proton therapy center in the Midwest, and Mevion Medical Systems announced today that the first four patients were treated at Kansas City Proton Institute on Dec. 19, with the MEVION S250i Proton Therapy System® .

Key Points: 
  • Kansas City Proton Institute (KCPI), the first physician-led proton therapy center in the Midwest, and Mevion Medical Systems announced today that the first four patients were treated at Kansas City Proton Institute on Dec. 19, with the MEVION S250i Proton Therapy System® .
  • (Photo: Business Wire)
    Kansas City Proton Institute recently opened the doors to its new facility that houses the region’s first Mevion compact proton therapy system.
  • The MEVION S250i system at KCPI also integrates an advanced 3D imaging system and will install the C-RAD Catalyst PT surface-guided tracking system, enabling a cutting-edge Image-Guided Proton Therapy configuration for high-precision patient positioning and intra-fraction motion management.
  • “We congratulate Kansas City Proton Institute for starting treatment with the Mevion proton therapy system,” said Tina Yu, PhD, chief executive officer and president of Mevion Medical Systems.

Installation of Proton Therapy System Begins at Kansas City Proton Institute

Retrieved on: 
Tuesday, January 24, 2023
Oncology, Health, Technology, Other Technology, Health Technology, General Health, Proton, Varian Medical Systems, Proton therapy, Patient, Risk, Multimedia, KCPI, Cancer, Medical imaging

Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that the 15-ton compact accelerator for the MEVION S250i Proton Therapy System® was delivered on January 20, to Kansas City Proton Institute (KCPI).

Key Points: 
  • Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that the 15-ton compact accelerator for the MEVION S250i Proton Therapy System® was delivered on January 20, to Kansas City Proton Institute (KCPI).
  • This milestone marks the beginning of the first true compact proton therapy system installation in Kansas City, and the fourth in the region.
  • Kansas City Proton Institute expects to begin treatments with the MEVION S250i system in Fall 2023 to treat all indications benefitting from the precision of proton therapy.
  • “The installation of Mevion’s cutting-edge proton therapy system is a giant step toward bringing the world’s most precise form of proton therapy to Kansas City and the Midwest region,” said Dr. Kenon Qamar, the lead radiation oncologist for Kansas City Proton Institute.